2,079
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Cripto-1 vaccination elicits protective immunity against metastatic melanoma

, , , , , & show all
Article: e1128613 | Received 12 Nov 2015, Accepted 30 Nov 2015, Published online: 11 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Felipe Gálvez-Cancino, Ernesto López, Evelyn Menares, Ximena Díaz, Camila Flores, Pablo Cáceres, Sofía Hidalgo, Ornella Chovar, Marcela Alcántara-Hernández, Vincenzo Borgna, Manuel Varas-Godoy, Flavio Salazar-Onfray, Juliana Idoyaga & Alvaro Lladser. (2018) Vaccination-induced skin-resident memory CD8+ T cells mediate strong protection against cutaneous melanoma. OncoImmunology 7:7.
Read now

Articles from other publishers (18)

Sanae El Harane, Bochra Zidi, Nadia El Harane, Karl-Heinz Krause, Thomas Matthes & Olivier Preynat-Seauve. (2023) Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine. Cells 12:7, pages 1001.
Crossref
John B. Pawlak & Gerard C. Blobe. (2021) TGF ‐β superfamily co‐receptors in cancer . Developmental Dynamics 251:1, pages 117-143.
Crossref
David W. Freeman, Elisa Rodrigues Sousa, Sofia Karkampouna, Eugenio Zoni, Peter C. Gray, David S. Salomon, Marianna Kruithof-de Julio & Benjamin T. Spike. (2021) Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal. International Journal of Molecular Sciences 22:18, pages 10164.
Crossref
Hiroko Ishii, Said M. Afify, Ghmkin Hassan, David S. Salomon & Masaharu Seno. (2021) Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy. Cancers 13:10, pages 2491.
Crossref
Elena Quaglino, Federica Cavallo & Laura Conti. (2020) Cancer stem cell antigens as targets for new combined anti-cancer therapies. The International Journal of Biochemistry & Cell Biology 129, pages 105861.
Crossref
Leorik Pereira da Silva, Mara Luana Batista Severo, Luiz Arthur Barbosa da Silva, Hébel Cavalcanti Galvão, Lélia Batista de Souza & Márcia Cristina da Costa Miguel. (2020) Teratocarcinoma-derived growth factor-1 (Cripto-1) is overexpressed in epithelial odontogenic lesions displaying more aggressive behaviour. Oral and Maxillofacial Surgery 24:4, pages 455-460.
Crossref
Katja Stifter, Jana Krieger, Leonie Ruths, Johann Gout, Medhanie Mulaw, Andre Lechel, Alexander Kleger, Thomas Seufferlein, Martin Wagner & Reinhold Schirmbeck. (2020) IFN-γ treatment protocol for MHC-I lo /PD-L1 + pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential . Journal for ImmunoTherapy of Cancer 8:2, pages e000692.
Crossref
Elisa Rodrigues Sousa, Eugenio Zoni, Sofia Karkampouna, Federico La Manna, Peter C. Gray, Marta De Menna & Marianna Kruithof-de Julio. (2020) A Multidisciplinary Review of the Roles of Cripto in the Scientific Literature Through a Bibliometric Analysis of its Biological Roles. Cancers 12:6, pages 1480.
Crossref
Katja Stifter, Iryna Dekhtiarenko, Jana Krieger, Alain Charles Tissot, Thomas Seufferlein, Martin Wagner & Reinhold Schirmbeck. (2020) A tumor-specific neoepitope expressed in homologous/self or heterologous/viral antigens induced comparable effector CD8+ T-cell responses by DNA vaccination. Vaccine 38:21, pages 3711-3719.
Crossref
Yuanfeng Wei, Jinfang Jiang, Chengyan Wang, Hong Zou, Xihua Shen, Wei Jia, Shan Jin, Lu Zhang, Jianming Hu, Lan Yang & Lijuan Pang. (2020) Prognostic value of cripto-1 expression in non-small-cell lung cancer patients: a systematic review and meta-analysis. Biomarkers in Medicine 14:4, pages 317-329.
Crossref
Clara H. Karches, Mohamed-Reda Benmebarek, Moritz L. Schmidbauer, Mathias Kurzay, Richard Klaus, Martina Geiger, Felicitas Rataj, Bruno L. Cadilha, Stefanie Lesch, Constanze Heise, Ramona Murr, Johannes vom Berg, Martin Jastroch, Daniel Lamp, Jian Ding, Peter Duewell, Gerhard Niederfellner, Claudio Sustmann, Stefan Endres, Christian Klein & Sebastian Kobold. (2019) Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy. Clinical Cancer Research 25:19, pages 5890-5900.
Crossref
Annamaria Sandomenico & Menotti Ruvo. (2019) Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers. Current Medicinal Chemistry 26:11, pages 1994-2050.
Crossref
Giuseppina Focà, Emanuela Iaccarino, Annalia Focà, Luca Sanguigno, Gustavo Untiveros, Maria Cuevas-Nunez, Luigi Strizzi, Antonio Leonardi, Menotti Ruvo & Annamaria Sandomenico. (2019) Development of conformational antibodies targeting Cripto-1 with neutralizing effects in vitro. Biochimie 158, pages 246-256.
Crossref
Kristina Witt, Maarten A. Ligtenberg, Laura Conti, Stefania Lanzardo, Roberto Ruiu, Tatjana Wallmann, Helena Tufvesson-Stiller, Benedict J. Chambers, Charlotte Rolny, Alvaro Lladser, Andreas Lundqvist, Federica Cavallo & Rolf Kiessling. (2018) Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma. Cancer Immunology Research 6:11, pages 1417-1425.
Crossref
Leorik Pereira Silva, Luiz Arthur Barbosa da Silva, Bruno Tavares Sedassari, Suzana Cantanhede Orsini Machado de Sousa, Joabe dos Santos Pereira, Lélia Batista de Souza & Márcia Cristina da Costa Miguel. (2018) Cripto-1 is overexpressed in carcinoma ex pleomorphic adenoma of salivary gland. European Archives of Oto-Rhino-Laryngology 275:6, pages 1595-1600.
Crossref
Stéphane Terry, Pierre Savagner, Sandra Ortiz‐Cuaran, Linda Mahjoubi, Pierre Saintigny, Jean‐Paul Thiery & Salem Chouaib. (2017) New insights into the role of EMT in tumor immune escape . Molecular Oncology 11:7, pages 824-846.
Crossref
Alice Agliano, Alfonso Calvo & Carol Box. (2017) The challenge of targeting cancer stem cells to halt metastasis. Seminars in Cancer Biology 44, pages 25-42.
Crossref
Maria Cristina Rangel, Daniel Bertolette, Nadia P. Castro, Malgorzata Klauzinska, Frank Cuttitta & David S. Salomon. (2016) Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer. Breast Cancer Research and Treatment 156:2, pages 211-226.
Crossref